Last update 04 Nov 2024

Resomelagon

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
AP 1189, AP-1189
Mechanism
MC1R agonists(Melanocortin receptor 1 agonists), MC3R agonists(Melanocortin receptor 3 agonists)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC16H18N6O4
InChIKeyFIESOFUABUPMMH-WAJHRQJSSA-N
CAS Registry1809420-72-1

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
InflammationPhase 2
US
01 Oct 2024
Nephrotic SyndromePhase 2
SE
30 Jan 2022
Respiratory Distress Syndrome, AdultPhase 2
SE
30 Jan 2022
Idiopathic Membranous GlomerulonephritisPhase 2
DK
31 Aug 2020
Infantile multisystem neurologic-endocrine-pancreatic diseasePhase 2
DK
31 Aug 2020
ProteinuriaPhase 2
DK
31 Aug 2020
Rheumatoid ArthritisPhase 2
DK
26 Aug 2019
Rheumatoid ArthritisPhase 2
NO
26 Aug 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
105
(50 mg AP1189)
rrwuizrbem(wsnroxifyu) = nzdkubcvip tldgfkncwh (kmkxcsjxqd, wvsvhiviks - qedbhocsnr)
-
10 Jul 2024
(100 mg AP1189)
rrwuizrbem(wsnroxifyu) = dxcbldritl tldgfkncwh (kmkxcsjxqd, egtwtmmqdp - yycwvmfmjy)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free